TELA Bio Inc

NASDAQ:TELA  
8.45
-0.44 (-4.95%)
Other Pre-Announcement

TELA Bio Reports Fourth Quarter Revenue Of $8.4 Mln

Published: 03/21/2022 20:19 GMT
TELA Bio Inc (TELA) - Tela Bio Reports Fourth Quarter and Full Year 2021 Financial Results.
Sees FY Revenue $40 Million to $45 Million.
Q4 Revenue Rose 48 Percent to $8.4 Million.
Qtrly Net Loss per Common Share, Basic and Diluted $0.59.